#763 on the rich list of 14,452 insiders
Serge Saxonov
Chief Executive Officer at 10x Genomics. Based in Pleasanton, California.
$249M
in disclosed stock, +$1.3M (+0.54%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 763rd of 14,452
- Companies held
- 1
- Largest holding
- TXG, 100.0% of total
- Latest SEC filing
- Nov 10, 2026
What the $249M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| 10x Genomics TXG Class B Common Stock | Indirectly (see filing footnote) | 1,750,000 | $57.38 | $100M | 40.4% | Form 4, Mar 23, 2026 |
| 10x Genomics TXG Class B Common Stock | Directly | 1,100,927 | $57.38 | $63.2M | 25.4% | Form 4, Mar 23, 2026 |
| 10x Genomics TXG Class A Common Stock | Directly | 1,019,249 | $57.38 | $58.5M | 23.5% | Form 4, Nov 10, 2026 |
| 10x Genomics TXG Class A Common Stock | Indirectly (see filing footnote) | 213,250 | $57.38 | $12.2M | 4.9% | Form 4, Nov 10, 2026 |
| 10x Genomics TXG Class B Common Stock | Through Polaris 2018 Irrevocable Trust | 180,938 | $57.38 | $10.4M | 4.2% | Form 4, Mar 23, 2026 |
| 10x Genomics TXG Class A Common Stock | Indirectly (see filing footnote) | 71,644 | $57.38 | $4.1M | 1.7% | Form 4, Nov 10, 2026 |
| 10x Genomics TXG Class A Common Stock | Through Andromeda Trust | 27 | $57.38 | $2K | 0.0% | Form 4, Nov 10, 2026 |
Share counts are the amounts Serge Saxonov reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Sold | TXG | 31,000 | $62.90 | $1.9M | View |
| Sep 22, 2026 | Sold | TXG | 1,000 | $78.23 | $78K | View |
| Sep 22, 2026 | Sold | TXG | 9,900 | $81.83 | $810K | View |
| Sep 22, 2026 | Sold | TXG | 9,300 | $80.90 | $752K | View |
| Sep 22, 2026 | Sold | TXG | 2,000 | $79.62 | $159K | View |
| Sep 22, 2026 | Sold | TXG | 2,800 | $82.37 | $231K | View |
| Aug 26, 2026 | Sold | TXG | 3,500 | $63.02 | $221K | View |
| Aug 26, 2026 | Sold | TXG | 6,494 | $63.98 | $415K | View |
| Aug 26, 2026 | Sold | TXG | 492 | $64.75 | $32K | View |
| Aug 24, 2026 | Sold | TXG | 18,545 | $63.02 | $1.2M | View |
| Jun 22, 2026 | Sold | TXG | 8,527 | $33.29 | $284K | View |
| Jun 22, 2026 | Sold | TXG | 1,661 | $36.16 | $60K | View |
| Jun 22, 2026 | Sold | TXG | 9,821 | $35.32 | $347K | View |
| Jun 22, 2026 | Sold | TXG | 9,991 | $34.28 | $342K | View |
| May 26, 2026 | Sold | TXG | 10,718 | $24.71 | $265K | View |
| May 22, 2026 | Sold | TXG | 18,175 | $24.44 | $444K | View |
| Apr 14, 2026 | Sold | TXG | 5,000 | $24.56 | $123K | View |
| Mar 24, 2026 | Sold | TXG | 5,000 | $19.52 | $98K | View |
| Mar 23, 2026 | Sold | TXG | 10,000 | $19.13 | $191K | View |
| Mar 2, 2026 | Sold | TXG | 14,292 | $22.67 | $324K | View |
| Mar 2, 2026 | Sold | TXG | 1,860 | $23.18 | $43K | View |
| Feb 23, 2026 | Sold | TXG | 9,632 | $18.58 | $179K | View |
| Nov 24, 2025 | Sold | TXG | 13,261 | $19.00 | $252K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 760 | Thomas A. Sansone Director, Jabil. St. Petersburg, FL | $249M |
| 761 | Tan Anthony Ping Yeow Chief Executive Officer, Grab Holdings | $249M |
| 762 | Glenn R. August Vice President, T. Rowe Price Group. New York, NY | $249M |
| 763 | Serge Saxonov Chief Executive Officer, 10x Genomics. Pleasanton, CA | $249M |
| 764 | Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER, Amphastar Pharmaceuticals. Rancho Cucamonga, CA | $248M |
| 765 | Sean Michael Oconnor Executive Vice-Chairman-Board, StoneX Group. New York, NY | $248M |
| 766 | Marc Grandisson CEO, Arch Capital Group. The Woodlands, TX | $247M |
Other 10x Genomics insiders
All TXG insiders- Bryan E. Roberts$28.7MDirector. #3921 overall
- Benjamin J. Hindson$28.0MSee Remarks. #3994 overall
- John R. Stuelpnagel$18.8MDirector. #5449 overall
- Adam Taich$18.2MChief Financial Officer. #5591 overall
- Mathai Mammen$10.3MDirector. #4893 overall
- Justin J. McAnear$8.2MInsider. #9282 overall
Questions
How much stock does Serge Saxonov own?
Serge Saxonov holds $248,801,688 in listed stock based on SEC filings and current prices, mostly 10x Genomics (TXG). That ranks 763rd on the Stock Rich List.
Is this Serge Saxonov's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Serge Saxonov last buy or sell stock?
The most recent open-market trade on file is a sale of 31,000 TXG shares on Nov 10, 2026 at $62.90.